Safety issues of gene therapy
- Authors: Ipatov S.E.1, Roumiantsev S.A.1
-
Affiliations:
- Federal Research Center of Pediatric Hematology, Oncology and Immunology
- Issue: No 1 (2010)
- Pages: 57-63
- Section: BASIC RESEARCH
- Published: 23.02.2010
- URL: https://oncohematology.abvpress.ru/ongm/article/view/663
- ID: 663
Cite item
Full Text
Abstract
By present time safety problems of gene therapy are widely discussed among scientists of all world. In this review results of clinical researches are summarized; explanations concerning side effects of vectors integration are given; factors that can cause genotoxicity are discussed. Approaches which can save or increase clinical efficacy of gene therapy with use as targets hematopoietic stem cells, thus significantly reduced risk of leukemia development and other side effects related to vectors including in genome, are presented.
Keywords
About the authors
S. E. Ipatov
Federal Research Center of Pediatric Hematology, Oncology and Immunology
Moscow
Russian FederationS. A. Roumiantsev
Federal Research Center of Pediatric Hematology, Oncology and Immunology
Author for correspondence.
Email: s.roumiantsev@hiidg.ru
Moscow
Russian FederationReferences
Supplementary files

